QuiaPEG Pharmaceuticals Holding AB Financial Flexibility Index
QuiaPEG Pharmaceuticals Holding AB financial flexibility index. QuiaPEG Pharmaceuticals Holding AB (QUIA) has a Financial Flexibility Index of -0.08x as of June 2025. Free cash flow of Skr-747.00K (operating CF Skr-747.00K minus capex Skr0.00) represents 0% of total liabilities (Skr8.81 Million). See QUIA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of QuiaPEG Pharmaceuticals Holding AB (2008–2024)
Financial flexibility index of QuiaPEG Pharmaceuticals Holding AB from 2008 to 2024. Historical Financial Flexibility Index trend for QuiaPEG Pharmaceuticals Holding AB across 17 annual periods. Check QuiaPEG Pharmaceuticals Holding AB earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
QuiaPEG Pharmaceuticals Holding AB Financial Flexibility Index by Year (2008–2024)
QuiaPEG Pharmaceuticals Holding AB financial flexibility index by year from 2008 to 2024. Year-by-year free cash flow to debt coverage for QuiaPEG Pharmaceuticals Holding AB. For the full cash flow conversion analysis, see QuiaPEG Pharmaceuticals Holding AB (QUIA) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.52x | Skr-9.71 Million | Skr-10.17 Million | Skr6.39 Million | ▼ -387.5% |
| 2023 | 0.53x | Skr14.11 Million | Skr-10.27 Million | Skr26.71 Million | ▲ +188.1% |
| 2022 | -0.60x | Skr-12.60 Million | Skr-18.18 Million | Skr21.03 Million | ▼ -23.6% |
| 2021 | -0.49x | Skr-11.52 Million | Skr-20.11 Million | Skr23.74 Million | ▲ +61.5% |
| 2020 | -1.26x | Skr-25.80 Million | Skr-28.31 Million | Skr20.47 Million | ▼ -194.1% |
| 2019 | -0.43x | Skr-10.19 Million | Skr-15.11 Million | Skr23.78 Million | ▲ +45.0% |
| 2018 | -0.78x | Skr-6.85 Million | Skr-10.39 Million | Skr8.78 Million | ▲ +49.0% |
| 2017 | -1.53x | Skr-10.22 Million | Skr-10.39 Million | Skr6.69 Million | ▼ -410.4% |
| 2016 | 0.49x | Skr1.80 Million | Skr1.80 Million | Skr3.65 Million | ▲ +43.9% |
| 2015 | 0.34x | Skr671.00K | Skr487.00K | Skr1.96 Million | ▼ -11.0% |
| 2014 | 0.38x | Skr1.50 Million | Skr1.49 Million | Skr3.89 Million | ▼ -25.8% |
| 2013 | 0.52x | Skr2.21 Million | Skr2.21 Million | Skr4.25 Million | ▲ +176.8% |
| 2012 | -0.68x | Skr-5.21 Million | Skr-5.21 Million | Skr7.71 Million | ▼ -173.4% |
| 2011 | 0.92x | Skr3.12 Million | Skr2.55 Million | Skr3.39 Million | ▼ -25.0% |
| 2010 | 1.23x | Skr3.32 Million | Skr2.65 Million | Skr2.71 Million | ▲ +69.1% |
| 2009 | 0.73x | Skr2.07 Million | Skr1.82 Million | Skr2.85 Million | ▼ -42.1% |
| 2008 | 1.25x | Skr4.33 Million | Skr956.00K | Skr3.46 Million | — |